This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rallied 6.3% to $9.98 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 21,840.95 and the Dow Jones Industrial Average rising 0.5% to 46,565.74.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 51.5% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 2.3% to $7.07, Fortress Biotech Inc. fell 11.5% to $2.47, and Viking Therapeutics Inc. rose 1.29% to $32.96.
Trading volume totaled 201,493, compared to the 50-day average of 189,522.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 01, 2026 16:34 ET (20:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments